000 01453nam a22003737a 4500
003 IQ-KoUCL
005 20160112093528.0
008 160112b xxu||||| |||| 00| 0 eng d
015 _aGBA059000
_2bnb
020 _a0444503161 :
_cNo price
039 0 _a2609
040 _aUk
_cDLC
082 0 4 _a616.075 CUT d 7512
_221
084 _aHE 011
_2blsrissc
100 _aedited by Gregory J. Downing.
245 0 0 _aBiomarkers and surrogate endpoints :
_bclinical research and applications : proceedings of the NIH-FDA conference held on 15-16 April 1999 in Bethesda, Maryland, USA /
260 _aAmsterdam ;
_aOxford :
_bElsevier,
_c2000.
300 _axxvii, 318 p. ;
_c25 cm.
490 1 _aExcerpta medica. International congress series ;
_v1205
500 _aIncludes index.
540 _aCurrent copyright fee: GBP22.50
_c5\1
_5Uk
650 0 _aBiochemical markers
_vCongresses.
_2 Diseases
653 _abiomarkers
653 _asurrogate endpoints
653 _aNIH
700 1 _aDowning, Gregory J.
710 2 _aNational Institutes of Health.
830 0 _aExcerpta medica.
_pInternational congress series ;
_v1205
856 _uhttp://www.elsevier.com/journals
_31850-9999
942 _2ddc
_cBK
945 _aInternational congress series -Amsterdam- Excerpta Medica then Elsevier Science ; vol 1205
999 _c137319
_d137319